McKesson has completed an $850 million acquisition of general ophthalmology and retina management services company PRISM Vision Holdings.
Through the acquisition, McKesson will own 80% of PRISM, according to an April 2 news release. PRISM will retain the other 20%.
McKesson will now be able to develop its first retinal and ophthalmology platform, expanding its clinical services and offerings.
The acquisition was first announced in early February.
The post McKesson completes ophthalmology acquisition appeared first on Becker’s ASC.
